Glioblastoma (GB) is the most malignant subtype of brain cancer derived from astrocytes in the brain. Radiotherapy is one of the standard treatments for GB patients, but its effectiveness is often limited by the radioresistance of aggressive GB cells. Higher dose of radiation needs to be applied to GB patients to eliminate these stubborn cells, but this also means more side effects on the adjacent healthy cells because the radiation beam could indistinguishably harm all cells exposed to it. In order to address this problem, various strategies have been studied to enhance the radiosensitivity among the radioresistant cell populations for targeted eradication of GB without harming other surrounding healthy cells. One of the promising strategies for radiosensitization is to use gold nanoparticles (AuNPs) which can enhance photoelectric effects within the radioresistant cells for higher killing efficiency even at low doses of radiation. Nonetheless, there is no evidence showing the capability of these nanoparticles to travel to brain tumor cells, therefore, the application of this nanotechnology is very much dependent on the development of a suitable carrier to deliver the AuNPs to the GB tumor sites specifically. In this review article, we discussed the potentials of neural stem cells (NSCs) as biological carriers to carry AuNPs to targeted GB tumor sites and provided new insights into the potential of NSC-based targeted delivery system for GB treatment. The information reported here may pave a new direction for clinical transformation of next-generation nanoparticle-assisted radiotherapy to optimize the efficacy of radiotherapy for GB treatment.
Citation: Mogesh Sababathy, Ghayathri Ramanathan, Suat Cheng Tan. Targeted delivery of gold nanoparticles by neural stem cells to glioblastoma for enhanced radiation therapy: a review[J]. AIMS Neuroscience, 2022, 9(3): 303-319. doi: 10.3934/Neuroscience.2022017
[1] | Jiaxin Shen, Yuqing Xia . Flag-transitive 2-designs with block size 5 and alternating groups. AIMS Mathematics, 2025, 10(5): 10308-10323. doi: 10.3934/math.2025469 |
[2] | Cenap Özel, Habib Basbaydar, Yasar Sñzen, Erol Yilmaz, Jung Rye Lee, Choonkil Park . On Reidemeister torsion of flag manifolds of compact semisimple Lie groups. AIMS Mathematics, 2020, 5(6): 7562-7581. doi: 10.3934/math.2020484 |
[3] | Simone Fiori . Coordinate-free Lie-group-based modeling and simulation of a submersible vehicle. AIMS Mathematics, 2024, 9(4): 10157-10184. doi: 10.3934/math.2024497 |
[4] | Yunpeng Xiao, Wen Teng . Representations and cohomologies of modified λ-differential Hom-Lie algebras. AIMS Mathematics, 2024, 9(2): 4309-4325. doi: 10.3934/math.2024213 |
[5] | Yupei Zhang, Yongzhi Luan . Dimension formulas of the highest weight exceptional Lie algebra-modules. AIMS Mathematics, 2024, 9(4): 10010-10030. doi: 10.3934/math.2024490 |
[6] | Amjad Hussain, Muhammad Khubaib Zia, Kottakkaran Sooppy Nisar, Velusamy Vijayakumar, Ilyas Khan . Lie analysis, conserved vectors, nonlinear self-adjoint classification and exact solutions of generalized (N+1)-dimensional nonlinear Boussinesq equation. AIMS Mathematics, 2022, 7(7): 13139-13168. doi: 10.3934/math.2022725 |
[7] | Nouf Almutiben, Ryad Ghanam, G. Thompson, Edward L. Boone . Symmetry analysis of the canonical connection on Lie groups: six-dimensional case with abelian nilradical and one-dimensional center. AIMS Mathematics, 2024, 9(6): 14504-14524. doi: 10.3934/math.2024705 |
[8] | Muhammad Asad Iqbal, Abid Ali, Ibtesam Alshammari, Cenap Ozel . Construction of new Lie group and its geometric properties. AIMS Mathematics, 2024, 9(3): 6088-6108. doi: 10.3934/math.2024298 |
[9] | Wei Shi . Nonexistence results of nonnegative solutions of elliptic equations and systems on the Heisenberg group. AIMS Mathematics, 2025, 10(5): 12576-12597. doi: 10.3934/math.2025567 |
[10] | Lilan Dai, Yunnan Li . Primitive decompositions of idempotents of the group algebras of dihedral groups and generalized quaternion groups. AIMS Mathematics, 2024, 9(10): 28150-28169. doi: 10.3934/math.20241365 |
Glioblastoma (GB) is the most malignant subtype of brain cancer derived from astrocytes in the brain. Radiotherapy is one of the standard treatments for GB patients, but its effectiveness is often limited by the radioresistance of aggressive GB cells. Higher dose of radiation needs to be applied to GB patients to eliminate these stubborn cells, but this also means more side effects on the adjacent healthy cells because the radiation beam could indistinguishably harm all cells exposed to it. In order to address this problem, various strategies have been studied to enhance the radiosensitivity among the radioresistant cell populations for targeted eradication of GB without harming other surrounding healthy cells. One of the promising strategies for radiosensitization is to use gold nanoparticles (AuNPs) which can enhance photoelectric effects within the radioresistant cells for higher killing efficiency even at low doses of radiation. Nonetheless, there is no evidence showing the capability of these nanoparticles to travel to brain tumor cells, therefore, the application of this nanotechnology is very much dependent on the development of a suitable carrier to deliver the AuNPs to the GB tumor sites specifically. In this review article, we discussed the potentials of neural stem cells (NSCs) as biological carriers to carry AuNPs to targeted GB tumor sites and provided new insights into the potential of NSC-based targeted delivery system for GB treatment. The information reported here may pave a new direction for clinical transformation of next-generation nanoparticle-assisted radiotherapy to optimize the efficacy of radiotherapy for GB treatment.
A 2-(v,k,λ) design D is a pair (P,B), where P is a set of v points, and B is a set of k-subsets of P called blocks, such that any 2 points are contained in exactly λ blocks. A flag is a point-block pair (α,B) with α∈B. The Fisher's inequality in [8, 1.3.8] shows that the number of blocks is at least v. Design D is said to be non-symmetric if v<b and non-trivial if 2<k<v−1. We always assume D to be non-trivial and non-symmetric in this paper. An automorphism of D is a permutation of P that leaves B invariant. All automorphisms of the design D form a group called the full automorphism group of D, denoted by Aut(D). Let G≤Aut(D). The design D is called point (block, flag)-transitive if G acts transitively on the set of points (blocks, flags) and point-primitive if G acts primitively on P, that is, G does not preserve a partition of P in classes of size c with 1<c<v.
For decades, works have been done on the classification of 2-designs admitting a transitive automorphism group. In 1988, Buekenhout, Delandtsheer, and Doyen first proved in [5] that the flag-transitive automorphism group of a 2-(v,k,1) design must be of affine or almost simple type. Then, the classification of flag-transitive 2-(v,k,1) designs was given in [6] by a six-person team, except for the case of the one-dimensional affine type. In recent years, some researchers have focused on into classifying 2-(v,k,λ) designs with general λ admitting flag-transitive automorphism group, such as [1,3,12,16,25,26,27]. Moreover, some of the works also considered classification of such designs admitting automorphism groups in a weaker condition, namely, block-transitive rather than flag-transitive [21,22,23,24].
The current paper tackles the 2-(v,k,λ) designs where λ is a prime. In [25], Zhang and Chen reduced the flag-transitive, point-primitive automorphism groups of such 2-designs either to the affine type (with an elementary abelian p-group as socle) or to the almost simple type (with a nonabelian simple socle). Hence, it is possible to classify such 2-designs based on the classification of simple groups. The aim of this paper is to consider the case when the socle of the automorphism group G is an exceptional simple group of Lie type. Note that groups G2(2), 2G2(3), 2B2(2), and 2F4(2) are not simple, so they are not under consideration in this work. It is also worth noting that the symmetric 2-designs with exceptional simple socle have been studied in [1,2,20]. The main result of the current paper is the following:
Theorem 1.1. Let D be a non-symmetric 2-(v,k,λ) design with λ prime and G a flag-transitive automorphism group of D. If the socle T of G is an exceptional Lie type simple group in characteristic p, then one of the following holds:
(1) T is 2B2(q) with q=22n+1>2 and (v,k,λ)=(q2+1,q,q−1), where q−1 is a Mersenne prime;
(2) T is G2(q), and (v,k,λ)=(q3(q3−1)2,q32,q+1) where q>2 is even and q+1 is a Fermat prime.
Remark 1.1. For the parameters in Theorem 1.1(1), the design D is described in [26]. For the parameters in Theorem 1.1(2), the existence of such a design remains uncertain at this time.
We begin with some well-established results about the parameters of 2-(v,k,λ) designs and the automorphism groups of them. For any point α, we denote by r the number of blocks that contain α, as it is a constant.
Lemma 2.1. ([8]) For a 2-(v,k,λ) design D, it is well known that
(1) bk=vr;
(2) λ(v−1)=r(k−1);
(3) λv<r2.
Lemma 2.2. ([8,Section 1.2]) Assume that G is an automorphism group of D. Then the flag-transitivity of G is equivalent to one of the following:
(1) G is point-transitive, and the point stabilizer Gα is transitive on all blocks that contain α;
(2) G is block-transitive, and the block stabilizer GB is transitive on the k points in block B.
Lemma 2.3. [7]) Assume that G is a flag-transitive automorphism group of D, and T is the socle of G. Then, we have
(1) r∣|Gα|, where Gα is the point-stabilizer of G;
(2) r∣λdi, where di is any nontrivial subdegree of G.
Assume that λ is a prime. Then either (λ,r)=1 or λ∣r. For the former case, by the results of [26], we immediately obtain the following Lemma:
Lemma 3.1. Assume that G and D satisfy the hypothesis of Theorem 1.1. If (λ,r)=1, then T=2B2(q) with q=22n+1≥8, and D is a 2-(q2+1,q,q−1) design with q−1 a Mersenne prime. In particular, 2n+1 is prime.
Therefore, we always assume λ∣r in the remaining content. Let r0=rλ. We get the following from Lemmas 2.1 and 2.3.
Lemma 3.2. Assume that D is a 2-(v,k,λ) design where λ is a prime divisor of r, and G is a flag-transitive automorphism group of D. Then we have
(1) v<λr20;
(2) r0 divides the greatest common divisor of |Gα|, v−1 and all nontrivial subdegrees of G.
Since G is point-primitive, the point stabilizer Gα is a maximal subgroup of G. In this section, we first deal with the case when Gα is a maximal parabolic subgroup of G.
Lemma 3.3. Assume that T=2B2(q) with q=22n+1>2. Then Gα cannot be the maximal parabolic subgroup of G.
Proof. If Gα is a maximal parabolic subgroup of G, we know that |Gα|=fq2(q−1) with f∣(2n+1) from [19], and hence v=q2+1. Then, according to (1) and (2) in Lemma 2.1 and the fact λ∣r, we further get k−1∣q2 and b=λq2(q2+1)k(k−1). Since G is flag-transitive, Lemma 2.2 implies that |GB|=|G|b=fk(k−1)(q−1)λ. All maximal subgroups of G can be read off from [19], and let M be any one of them with GB≤M. The fact that |GB| divides |M| implies that M is the maximal parabolic subgroup of G, and k(k−1) divides λq2. This forces k=λ, for otherwise k(k−1)∣q2, which is a contradiction. It follows that GB is primitive on B, and so TB is transitive on B. Namely, |TB:Tγ,B|=k for any point γ∈B. On the other hand, since M is parabolic, there exists a point α such that M=Gα. That is to say, TB≤Tα and therefore Tγ,B≤Tγ,α for γ∈B. Since the stabilizer of any two points in 2B2(q) is a cyclic group of order q−1 by [9, p.187], |Tγ,B| divides (q−1). Also, |T:Tγ,α| divides bk by the flag-transitivity of G. It follows that (k−1)∣λ, which holds only when λ=k=2, for it has been proved that k=λ above. This is impossible as D is nontrivial.
Lemma 3.4. Assume that T=2G2(q) with q=32n+1>3. Then Gα cannot be the maximal parabolic subgroup of G.
Proof. If Gα is the maximal parabolic subgroup of G, then we know that |Gα|=fq3(q−1) with f∣(2n+1) from [11], and so v=q3+1. Similar as to Lemma 3.3, we have
b=λv(v−1)k(k−1)=λq3(q3+1)k(k−1) |
and k−1∣q3. Let f1 be a divisor of f such that |GB:TB|=f1. Then by the flag-transitivity of G, we get
|TB|=f(q−1)k(k−1)f1λ. |
Here, we also consider the maximal subgroups M of 2G2(q) such that TB≤M. From [11], either M is parabolic, or M≅Z2×PSL2(q).
If M is a parabolic subgroup, then k(k−1)∣λq3. Since k−1∣q3, we have k∣λ and therefore λ=k. It follows that λ−1∣q3 and λ=3n1+1, which forces λ=k=2, for λ is prime. However, now we get b=q3(q3+1)>(v2), which is obviously impossible. Hence, in the remaining part of the proof, we assume that TB≤Z2×PSL2(q).
According to the list of the maximal subgroups of PSL2(q) in [4, Tables 8.1 and 8.2], TB is isomorphic to a subgroup of Z2×A4, Z2×Dq±1, Z2×([q]:Zq−12) or Z2×PSL2(q0) with qℓ0=q=32n+1. Obviously, the former two cases are impossible as k−1∣q3. Then, if TB≲Z2×([q]:Zq−12), we also have λ=k, a contradiction again. For the last case, the condition that |TB| divides |Z2×PSL2(q0)| forces q0=q, which implies that TB is isomorphic to Z2×PSL2(q) or PSL2(q). Then, by |T:TB|∣b, we have k(k−1)∣q(q+1)λ. This, together with k−1∣q2, implies that k−1∣q when λ≠3, and k−1∣3q when λ=3. Furthermore, the facts that q+1 is the smallest degree of non-trivial action of PSL2(q) since q is an odd power of 3 and that |TB:Tα,B| divides k imply k=q+1. Hence, |TB|=fk(k−1)(q−1)f1λ=q(q2−1)a, with a=1 or 2 when TB is Z2×PSL2(q) or PSL2(q), respectively. It follows that λ∣f when TB is Z2×PSL2(q), or λ=2 when TB is PSL2(q).
Let R be the Ree unital of order q (which is a 2-(q3+1,q+1,1) design). For the former case, let σ be the central involution of Z2×PSL2(q). It can be deduced from [15] that σ fixes a block ℓ of R pointwise and preserves a point-partition Sσ of R∖ℓ into q2−q blocks, each of them invariant by σ. Now, Z2×PSL2(q) induces PSL2(q) on Sσ∪{ℓ}, and PSL2(q) preserves ℓ acting on this one in its natural 2-transitive action of degree q+1. Further, PSL2(q) partitions Sσ into two orbits each of length q2−q2. Thus, ℓ is the unique Z2×PSL2(q)-orbit of points of R of length q+1. Note that k=q+1, which means B=ℓ. This means that |BG|=|ℓG|=q2(q2−q+1) by [6], and so λ=1, which contradicts with λ being prime. For the latter case, the block stabilizer Tℓ for the Ree unital is Z2×PSL2(q), and Z2 fixed all points in ℓ. However, since αTB⊆αTℓ and |αTB|=|αTℓ|=q+1, we have αTB=αTℓ. This means that Z2 fixed all points in B, and so Z2∈TB, an obvious contradiction.
For the remaining possibility of T in T, where
T={2F4(q),3D4(q),G2(q),F4(q),Eϵ6(q),E7(q),E8(q)}, |
we use the following Lemma from [14] to prove that Gα cannot be the maximal parabolic subgroup. Note that in the following we denote by np the p-part of n and np′ the p′-part of n, i.e., np=pt where pt∣n but pt+1∤n, and np′=n/np.
Lemma 3.5. ([14]) Assume that T is a simple group of Lie type in characteristic p and acts on the set of cosets of a maximal parabolic subgroup. Then T has a unique subdegree which is a power of p except when T is Ld(q), Ω+2m(q) (m is odd) or E6(q).
Lemma 3.6. If T∈T, then Gα cannot be a parabolic subgroup of G.
Proof. By Lemma 3.5, for all cases where T∈T∖{E6(q)}, there is a unique subdegree which is a power of p. Then, Lemma 3.2 implies that r0 divides |v−1|p. Since we also have λ divides |Gα|, we can easily check that r0 is too small to satisfy the condition v<λr20. Therefore, we assume that T=E6(q). If G contains a graph automorphism, or Gα∩T is P2 or P4, then there is also a unique subdegree that is a power of p. However, r0 is too small again. If Gα∩T is P3 with type A1A4, we have λ≤q5−1q−1 by λ∣|Gα| and
v=(q3+1)(q4+1)(q9−1)(q6+1)(q4+q2+1)(q−1). |
Moreover, from [1, Proposition 6.3], we know that there exist two nontrivial subdegrees: q13q5−1q−1 and q(q5−1)(q4−1)(q−1)2. Lemma 3.2 then implies that r divides λqq5−1q−1. However, the condition v<λr20 cannot be satisfied again. If Gα∩T is P1 with type D5, then
v=(q8+q4+1)(q9−1)q−1, |
and there exist two nontrivial subdegrees (see [13]): q(q3+1)(q8−1)(q−1) and q8(q4+1)(q5−1)(q−1). It follows that r∣λq(q4+1). This, together with λ∣|Gα|, implies that r2<λ2q2(q4+1)2<λv, which is contradictive with Lemma 2.1.
In this section, we assume that Gα is a non-parabolic maximal subgroup of G.
Lemma 3.7. Assume that G and D satisfy the hypothesis of Theorem 1.1. Then, |G|<|Gα|3.
Proof. From Lemma 2.3, we know that r divides every nontrivial subdegree of G, and so r divides |Gα|. Since v<r2 by (3) of Lemma 2.1, it follows that |G|<|Gα|3.
Lemma 3.7 implies that Gα is a large maximal non-parabolic subgroup of G. The type of Gα can be read from [1, Table 2]. Note that Theorem 1.1(2) just corresponds to the non-parabolic case here, with T=G2(q) and the type of Gα being SLϵ3(q).2.
Lemma 3.8. Assume that G and D satisfy the hypothesis of Theorem 1.1. If T=G2(q) and the type of Gα is SLϵ3(q).2 with ϵ=±, then ϵ=−, T is flag-transitive on D, and the parameters of D are (v,b,r,k,λ)=(q3(q3−1)2,(q+1)(q6−1),(q+1)(q3+1),q32,q+1), where q is even, and λ=q+1 is a Fermat prime.
Proof. It is obvious that |Tα|=2q3(q2−1)(q3−ϵ1), and hence v=12q3(q3+ϵ1). We first deal with the case when q is even. Since G2(2) is not simple (G2(2)≅PSU3(3):2), we assume that q>2. From [17, Section 3, Case 8], we know that r divides λ(q3−ϵ1). Then, the equality λ(v−1)=r(k−1) from Lemma 2.1 implies that there exists an odd integer t dividing (q3−ϵ1) such that
k=t(q3+ϵ2)2+1andr=λ(q3−ϵ1)t. |
Obviously, the fact that k<r implies t<λ. Moreover, by Lemma 2.1 we have
b=λv(v−1)k(k−1)=λq3(q6−1)(q3+ϵ2)4k(k−1)=λq3(q6−1)2kt. | (3.1) |
Note also that (2k,q3−ϵ1)∣3t+ϵ2, (2k,q3+1)∣t+ϵ2, (k,q32)∣t+ϵ1, and therefore (2k,q2−1)∣(t+ϵ2)(3t+ϵ2). Since b is an integer, it follows from (3.1) that k∣λq32(q3−ϵ1)(q3+ϵ1). Hence, we have
t(q3+ϵ2)2+1∣λ(t+ϵ2)(t+ϵ1)(3t+ϵ2). | (3.2) |
Since 3t+ϵ2≤5t, it follows that q3+ϵ2<10λ(t+ϵ2)(t+ϵ1) except when t=1 and ϵ=−. When t≠1, the above together with t<λ further implies that λ cannot be a prime divisor of |Out(T)|, and hence λ divides |SLϵ3(q).2|.
In the following, we prove that t=1. Obviously, t≠2, for t is odd. When t≥3, we have rλ≤13(q3−ϵ1) and 3t2<λ by t(q3+ϵ2)2<k≤r≤λ(q3−ϵ1)3. Now, assume that λ∣k. Then λ divides (2q3(q2−1)(q3−ϵ1),2k), and it follows that λ∣4(t+ϵ1)(t+ϵ2)(3t+ϵ2)2. Since 32t<λ, we have λ=3t+ϵ2, or ϵ=+ and λ=3t+22. If λ=3t+2ϵ, then k<r forces (t,λ,ϵ)=(5,17,+), (5,13,−), (3,11,+), (3,7,−), or (1,5,+). Note that k∣λ(t+ϵ2)(t+ϵ1)(3t+ϵ2), and we check each case and know that it is impossible. If λ=3t+22, then we get (t,λ)=(4,7), which can be ruled out similarly. Hence, λ∤k, and it follows (3.2) that t>q. On the other hand, since |T:TB|∣b, there exists an integer f1 dividing f such that f1|T:TB|=b and
|TB|=2f1q3(q2−1)kλt. |
Since λ∤k and λ>t>q≥2, λ is a divisor of f1, (q−1), q+1, or q, and so λ≤q+1. Since q<t<23λ, we get a contradiction. Therefore, t=1 as we claim.
Let t=1. Then, rλ=(q3−ϵ1), and k=(q3+2ϵ)2+1 with q even. If ϵ=+, then r=λ(q3−1), and k=q3+42. Since b is an integer, we get that q3+4 divides λq3(q6−1). It follows that q3+4∣60λ, and so λ divides q3+4, which is impossible as λ is a prime divisor of 2q3(q2−1)(q3−1). We now assume that ϵ=−. Then, k=q32 and b=λ(q6−1), and r=λ(q3+1) for q≥4. Moreover, in this case |TB|=f1q6(q2−1)λ and we further find that TB is contained in a maximal parabolic subgroup M=q5:GL2(q) of G2(q). Since G is flag-transitive, Lemma 2.2 implies that |SU3(q).2:Tα,B| divides λ(q3+1). Using the maximal subgroup list for SU3(q) provided in [4, Tables 8.5 and 8.6], we get that Tα,B is isomorphic to a subgroup of M1=q3:Cq2−1.2. If Tα,B=M1 or λ∤q2−1, then Tα,B contains a cyclic group of order q2−1, which contradicts Tα,B≤TB≤q5:GL2(q). Hence, |M1:Tα,B|=λ divides q2−1. This also implies that T is flag-transitive, and so |T:M||M:TB|=λ(q6−1). It follows that |M:TB|=|GL2(q):TB∩GL2(q)|=λ(q−1), which gives |TB∩GL2(q)|=q(q2−1)λ. Then, using the list of maximal subgroups of SL(2,q) provided in [4, Tables 8.1 and 8.2], we get that λ∤q−1, and so λ∣q+1, which further implies that λ=q+1. This is to say, if such design exists, then the design parameters tuple is (v,b,r,k,λ)=(q3(q3−1)2,(q+1)(q6−1),(q+1)(q3+1),q32,q+1), where λ=q+1 is a Fermat prime.
Now, we assume that q is odd. Then, we conclude that r divides λ(q3−ϵ1)2 from [17, Section 4, Case 1, i=1]. Let rt=λ(q3−ϵ1)2. Similar as in the even case, we also have t=1. That is to say, k=q3+ϵ2+1 and r=λ(q3−ϵ1)2. When ϵ=+, the fact of k dividing λq3(q6−1) q3+3 implies that q3+3 divides 24λ, and so λ divides q3+3, which is impossible as λ is a prime divisor of 2q3(q2−1)(q3−1). If ϵ=−, we have k=q3−1, and so b=λq3(q3+1)4. We consider a maximal subgroup M containing TB. It is proven later that M≅TB≅SL3(q).2 and hence that is unique. The fact that |T:M|∣b implies that M is SL3(q).2 by [4,Tables 8.41 and 8.42] and that |T:M|=q3(q3+1)2. It follows that 2|M:TB|∣λ, which forces λ=2 and M=TB≅SL3(q).2. Since Tα≅SU3(q).2 and r=q3+1, we have Tα,B≅q3.Cq2−1.2 or q3.Cq2−1. According to the maximal subgroups of SL3(q) in [4, Tables 8.3 and 8.4], we know that Tα,B is isomorphic to a subgroup of q2.GL2(q).2, which is impossible.
All other types of Gα in [1, Table 2], except two cases which we will discuss in Lemma 3.10, can be ruled out using the method stated below. First, for each possibility of Gα, the order of Gα and the value of v can be determined. We can hence get an upper bound of λ according to λ∣|Gα|. Then, to get an upper bound of r0, we consider the divisors of |Gα| in two parts: ∏i1i=1Φi for which Φi divides v, and ∏i2j=1Ψj=|Gα|/∏i1i=1Φi. Obviously, all Φi are coprime with v−1. For each Ψj, we calculate the remainder ˉΨj of Ψj divided by v−1. This implies that (|Gα|,v−1) divides |Out(T)|∏i2j=1ˉΨj, which implies that r0≤|Out(T)|∏i2j=1ˉΨj. Finally, one can check that the values of r0 for all these cases are too small to satisfy the condition that v<λr20. That is, no new designs arise in these cases. To be more explicit, we take T=E8(q) as an example.
Lemma 3.9. Assume that G and D satisfy the hypothesis of Theorem 1.1. If T=E8(q) with q=pe, then Gα cannot be a non-parabolic maximal subgroup of G.
Proof. Let T=E8(q). Then, it follows from [1, Table 2] that the type of Gα is one of the following:
{A1(q)E7(q),D8(q),E8(q12),E8(q13),Aϵ2(q)Eϵ6(q)}. |
For the case that Gα is of type A1(q)E7(q), we have λ<q8 since λ∣|Gα| and v=q56(q6+1)(q10+1)(q12+1)q30−1q2−1 by v=|G:Gα|. Obviously, q(q6+1)∣v and q30−1q2−1∣v, which also implies q6−1q2−1∣v and q10−1q2−1∣v. This means (|Gα|,v−1) divides |Out(T)|(q2−1)5(q8−1)(q14−1)(q18−1). Since r0∣(|Gα|,v−1), we have r0<q51. However, Lemma 3.2 shows q112<v<λr20<q110, a contradiction.
For the case that Gα is of type D8(q), we have λ<q7 and
v=q64(q12+q6+1)(q16+q8+1)(q10+1)(q30−1)q4−1. |
Since v−1≡2(modq4+1), (v−1,q4+1)=2 or 1. This, together with q∣v and q30−1q2−1∣v, implies that (|Gα|,v−1) divides 4|Out(T)|(q2−1)3(q4−1)3(q12−1)(q14−1). It follows that r0≤4|Out(T)|q44<4q45, and q128<v<λr20<4q97, which is a contradiction.
Assume that Gα is of type E8(q12). Then, λ≤q15 and v=q60(q+1)(q4+1)(q6+1)(q7+1)(q9+1)(q10+1)(q12+1)(q15+1). Since q, q3+1, q4+1, q5+1, and q6+1 are divisors of v, we get that (|Gα|,v−1) divides |Out(T)|(q−1)2(q3−1)2(q5−1)(q7−1)(q9−1)(q15−1). It follows that r0<q45, and so q124<v<λr20<q105, a contradiction again.
Assume that Gα is of type Aϵ2(q)Eϵ6(q) or E8(q13). Then, since Gα is non-parabolic, the Tits lemma in [18, 1.6] implies that p divides v=|G:Gα|, and so (|Gα|,v−1) is coprime with p. It follows that r0≤|Gα|p′ as r0 divides (|Gα|,v−1). This implies that v<λ|Out(T)|2|Tα|2p′ by Lemma 3.2, which cannot be satisfied when Gα is of type Aϵ2(q)Eϵ6(q) or E8(q13).
Lemma 3.10. Assume that G and D satisfy the hypothesis of Theorem 1.1. Then the type of Gα cannot be either (q−ϵ1)Dϵ5(q) when T=Eϵ6(q) or (q−ϵ1)Eϵ6(q) when T=E7(q).
Proof. Assume that T is Eϵ6(q) and Gα is of type (q−ϵ1)Dϵ5(q). Then, λ<2q4 as λ divides |Gα| and v=q16(q9−ϵ1)(q12−1)(3,q−1)(q−ϵ1)(q4−1). In addition, we know from [1, Theorem 4.1] that there exist two subdegrees: q8(q5−ϵ)(q4+1) and q10(q3+ϵ)(q8−1). Since r0 divides the greatest common divisors of every non-trivial subdegree and v−1 (Lemma 2.3), we have (r0,p)=1, and so r0∣2(q−ϵ1)(q4+1), which implies that r0 is too small to satisfy v<λr20 again.
If T is E7(q) and Gα is of type (q−ϵ1)Eϵ6(q), we have λ≤2q6 and v=q27(q5+ϵ1)(q9+ϵ1)(q14−1)q−ϵ1. [1, Theorem 4.1] shows that there exist two subdegrees, which divide q12(q5−ϵ)(q9−ϵ) and(4,qm−1ϵ)q16(q5−ϵ)(q12−1q4−1), respectively. However, by Lemma 2.3 we know that r0 is too small again.
Proof of Theorem 1.1. It follows immediately from Lemmas 3.1–3.10.
In this paper, we figure out all possible parameters of 2-(v,k,λ) designs D (with λ prime) that admit flag-transitive point-primitive automorphism groups with an exceptional Lie type socle. Our work contributes to the classification of flag-transitive 2-(v,k,λ) designs. In addition, the cases that the automorphism groups of such designs with classical socle will be the main focus in our future work.
Y. Zhang: Data curation, writing-review and editing; J. Shen: Writing-original draft. All authors have read and agreed to the published version of the manuscript.
The authors declare they have not used artificial intelligence (AI) tools in the creation of this article.
The authors would like to thank the anonymous referees for corrections and valuable comments that led to the improvement of this paper.
This work is financially supported by the National Natural Science Foundation of China (Grant number: 12301020 and 12201469) and the Science and Technology Projects in Guangzhou (Grant number: 2023A04J0027).
The authors declare no conflict of interest.
[1] |
D'Alessio A, Proietti G, Sica G, et al. (2019) Pathological and molecular features of glioblastoma and its peritumoral tissue. Cancers 11: 469. https://doi.org/10.3390/cancers11040469 ![]() |
[2] | Arbab AS, Ali MM (2020) Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways. Novel Approaches Cancer Study 4: 398. https://doi.org/10.31031/nacs.2020.04.000596 |
[3] |
Davis ME (2016) Glioblastoma: Overview of disease and treatment. Clin J Oncol Nurs 20: 1-8. https://doi.org/10.1188/16.CJON.S1.2-8 ![]() |
[4] |
Miller KD, Ostrom QT, Kruchko C, et al. (2021) Brain and other central nervous system tumor statistics, 2021. CA-Cancer J Clin 71: 381-406. https://doi.org/10.3322/caac.21693 ![]() |
[5] |
Batash R, Asna N, Schaffer P, et al. (2017) Glioblastoma Multiforme, Diagnosis and Treatment; Recent Literature Review. Curr Med Chem 24: 3002-3009. https://doi.org/10.2174/0929867324666170516123206 ![]() |
[6] |
Silantyev AS, Falzone L, Libra M, et al. (2019) Current and Future Trends on Diagnosis and Prognosis of Glioblastoma: From Molecular Biology to Proteomics. Cells 8: 863. https://doi.org/10.3390/cells8080863 ![]() |
[7] |
Ma C, Nguyen HPT, Jones JJ, et al. (2022) Extracellular Vesicles Secreted by Glioma Stem Cells Are Involved in Radiation Resistance and Glioma Progression. Int J Mol Sci 23: 2770. https://doi.org/10.3390/ijms23052770 ![]() |
[8] |
Vogelbaum MA (2012) Does extent of resection of a glioblastoma matter?. Clin Neurosur 59: 79-81. https://doi.org/10.1227/NEU.0b013e31826b2e75 ![]() |
[9] |
Perrini P, Gambacciani C, Weiss A, et al. (2017) Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis. J Neuro-Oncol 131: 585-91. https://doi.org/10.1007/s11060-016-2330-7 ![]() |
[10] |
Wann A, Tully PA, Barnes EH, et al. (2018) Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study. J Neuro-Oncol 137: 409-415. https://doi.org/10.1007/S11060-017-2731-2 ![]() |
[11] |
Montemurro N, Fanelli GN, Scatena C, et al. (2021) Surgical outcome and molecular pattern characterization of recurrent glioblastoma multiforme: A single-center retrospective series. Clin Neurol Neurosur 207: 106735. https://doi.org/10.1016/j.clineuro.2021.106735 ![]() |
[12] |
Sacko O, Benouaich-Amiel A, Brandicourt P, et al. (2021) The impact of surgery on the survival of patients with recurrent glioblastoma. Asian J Neurosur 16. https://doi.org/10.4103/ajns.ajns_180_20 ![]() |
[13] |
Brennan PM, Borchert R, Coulter C, et al. (2021) Second surgery for progressive glioblastoma: a multi-centre questionnaire and cohort-based review of clinical decision-making and patient outcomes in current practice. J Neuro-Oncol 153. https://doi.org/10.1007/s11060-021-03748-0 ![]() |
[14] |
Robin AM, Lee I, Kalkanis SN (2017) Reoperation for Recurrent Glioblastoma Multiforme. Neurosurg Clin N Am 28: 407-28. https://doi.org/10.1016/J.NEC.2017.02.007 ![]() |
[15] |
Stupp R, Mason WP, van den Bent MJ, et al. (2005) Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma. New Engl J Med 352: 987-996. https://doi.org/10.1056/nejmoa043330 ![]() |
[16] |
Fan CH, Liu WL, Cao H, et al. (2013) O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas. Cell Death Dis 4: e876. https://doi.org/10.1038/cddis.2013.388 ![]() |
[17] |
Strobel H, Baisch T, Fitzel R, et al. (2019) Temozolomide and Other Alkylating Agents in Glioblastoma Therapy. Biomedicines 7: 69. https://doi.org/10.3390/biomedicines7030069 ![]() |
[18] |
Auffinger B, Spencer D, Pytel P, et al. (2015) The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence. Expert Rev Neurother 15: 741-752. https://doi.org/10.1586/14737175.2015.1051968 ![]() |
[19] |
Alves AL V, Gomes INF, Carloni AC, et al. (2021) Role of glioblastoma stem cells in cancer therapeutic resistance: a perspective on antineoplastic agents from natural sources and chemical derivatives. Stem Cell Res Ther 12: 206. https://doi.org/10.1186/s13287-021-02231-x ![]() |
[20] | Singh N, Miner A, Hennis L, et al. (2021) Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review. Cancer Drug Resist 4: 17-43. https://doi.org/10.20517/cdr.2020.79 |
[21] |
Armocida D, Frati A, Salvati M, et al. (2020) Is Ki-67 index overexpression in IDH wild type glioblastoma a predictor of shorter Progression Free survival? A clinical and Molecular analytic investigation. Clin Neurol Neurosur 198: 106126. https://doi.org/10.1016/j.clineuro.2020.106126 ![]() |
[22] |
Alkhaibary A, Alassiri AH, AlSufiani F, et al. (2019) Ki-67 labeling index in glioblastoma; does it really matter?. Hematology/Oncology Stem Cell Ther 12: 82-88. https://doi.org/10.1016/j.hemonc.2018.11.001 ![]() |
[23] |
Smith HR (2015) Depression in cancer patients: Pathogenesis, implications and treatment (review). Oncol Lett 9: 1509-14. https://doi.org/10.3892/ol.2015.2944 ![]() |
[24] | Huh DH, Kim S (2020) History of Radiation Therapy Technology. Korean Soc Med Phys 31: 124-134. https://doi.org/10.14316/PMP.2020.31.3.124 |
[25] |
Baskar R, Lee KA, Yeo R, et al. (2012) Cancer and radiation therapy: Current advances and future directions. Int J Med Sci 9: 193-199. https://doi.org/10.7150/ijms.3635 ![]() |
[26] | National Cancer InstituteExternal Beam Radiation Therapy (2020). https://doi.org/10.32388/h102yn |
[27] |
Chalmers AJ, Ruff EM, Martindale C, et al. (2009) Cytotoxic Effects of Temozolomide and Radiation are Additive- and Schedule-Dependent. Int J Radiat Oncol 75: 1511-1519. https://doi.org/10.1016/j.ijrobp.2009.07.1703 ![]() |
[28] | Ali MY, Oliva CR, Noman ASM, et al. (2020) Radioresistance in glioblastoma and the development of radiosensitizers. Cancers 12: 1-29. https://doi.org/10.3390/cancers12092511 |
[29] |
Higby GJ (1982) Gold in medicine - A review of its use in the west before 1900. Gold Bull 15: 130-40. https://doi.org/10.1007/BF03214618 ![]() |
[30] |
Fricker SP (1996) Medical uses of gold compounds: Past, present and future. Gold Bull 29: 53-60. https://doi.org/10.1007/bf03215464 ![]() |
[31] |
Giljohann DA, Seferos DS, Daniel WL, et al. (2010) Gold nanoparticles for biology and medicine. Angew Chem Int Edit 49: 3280-94. https://doi.org/10.1002/anie.200904359 ![]() |
[32] |
Hu X, Zhang Y, Ding T, et al. (2020) Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front Bioeng Biotech 8: 990. https://doi.org/10.3389/FBIOE.2020.00990/BIBTEX ![]() |
[33] |
Hu X, Zhang Y, Ding T, et al. (2020) Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front Bioeng Biotech 8: 990. https://doi.org/10.3389/fbioe.2020.00990 ![]() |
[34] |
Frens G (1973) Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions. Nature Phys Sci 241: 20-2. https://doi.org/10.1038/physci241020a0 ![]() |
[35] |
Brust M, Walker M, Bethell D, et al. (1994) Synthesis of thiol-derivatised gold nanoparticles in a two-phase Liquid–Liquid system. J Chem Soc Chem Commun, : 801-802. https://doi.org/10.1039/C39940000801 ![]() |
[36] |
Yeh YC, Creran B, Rotello VM (2012) Gold Nanoparticles: Preparation, Properties, and Applications in Bionanotechnology. Nanoscale 4: 1871-1880. https://doi.org/10.1039/C1NR11188D ![]() |
[37] |
Kim M, Lee JH, Nam JM (2019) Plasmonic Photothermal Nanoparticles for Biomedical Applications. Adv Sci 6: 1900471. https://doi.org/10.1002/advs.201900471 ![]() |
[38] |
Kim SE, Lee BR, Lee H, et al. (2017) Near-Infrared Plasmonic Assemblies of Gold Nanoparticles with Multimodal Function for Targeted Cancer Theragnosis. Sci Rep 7: 1-10. https://doi.org/10.1038/s41598-017-17714-2 ![]() |
[39] |
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine 3: 703-717. https://doi.org/10.2217/17435889.3.5.703 ![]() |
[40] |
Gerosa C, Crisponi G, Nurchi VM, et al. (2020) Gold nanoparticles: A new golden Era in oncology?. Pharmaceuticals 13: 192. https://doi.org/10.3390/ph13080192 ![]() |
[41] |
Gupta R, Xie H (2018) Nanoparticles in daily life: Applications, toxicity and regulations. J Environ Pathol Tox 37: 209-230. https://doi.org/10.1615/JEnvironPatholToxicolOncol.2018026009 ![]() |
[42] |
Kong FY, Zhang JW, Li RF, et al. (2017) Unique roles of gold nanoparticles in drug delivery, targeting and imaging applications. Molecules 22: 1445. https://doi.org/10.3390/molecules22091445 ![]() |
[43] |
Singh P, Pandit S, Mokkapati VRSS, et al. (2018) Gold nanoparticles in diagnostics and therapeutics for human cancer. Int J Mol Sci 19: 1979. https://doi.org/10.3390/ijms19071979 ![]() |
[44] | Chen YS, Hung YC, Hong MY, et al. (2012) Control of in vivo transport and toxicity of nanoparticles by tea melanin. J Nanomater 2012. https://doi.org/10.1155/2012/746960 |
[45] |
Lasagna-Reeves C, Gonzalez-Romero D, Barria MA, et al. (2010) Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochem Bioph Res Co 393: 649-655. https://doi.org/10.1016/j.bbrc.2010.02.046 ![]() |
[46] | Sani A, Cao C, Cui D (2021) Toxicity of gold nanoparticles (AuNPs): A review. Biochem Biophys Rep 26: 100991. https://doi.org/10.1016/j.bbrep.2021.100991 |
[47] |
Sun PP, Lai CS, Hung CJ, et al. (2021) Subchronic oral toxicity evaluation of gold nanoparticles in male and female mice. Heliyon 7: E06577. https://doi.org/10.1016/j.heliyon.2021.e06577 ![]() |
[48] |
Berce C, Lucan C, Petrushev B, et al. (2016) In vivo assessment of bone marrow toxicity by gold nanoparticle-based bioconjugates in CrL:CD1(ICR) mice. Int J Nanomed 11: 4261-4273. https://doi.org/10.2147/IJN.S108711 ![]() |
[49] |
Schaeublin NM, Braydich-Stolle LK, Schrand AM, et al. (2011) Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 3: 410-420. https://doi.org/10.1039/c0nr00478b ![]() |
[50] |
Schneider T, Westermann M, Glei M (2017) In vitro uptake and toxicity studies of metal nanoparticles and metal oxide nanoparticles in human HT29 cells. Arch Toxicol 91: 3517-3527. https://doi.org/10.1007/s00204-017-1976-z ![]() |
[51] |
Bahamonde J, Brenseke B, Chan MY, et al. (2018) Gold Nanoparticle Toxicity in Mice and Rats: Species Differences. Toxicol Pathol 46. https://doi.org/10.1177/0192623318770608 ![]() |
[52] |
Glazer ES, Zhu C, Hamir AN, et al. (2011) Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology 5: 459-468. https://doi.org/10.3109/17435390.2010.516026 ![]() |
[53] |
Kim KT, Zaikova T, Hutchison JE, et al. (2013) Gold nanoparticles disrupt zebrafish eye development and pigmentation. Toxicol Sci 133: 275-288. https://doi.org/10.1093/toxsci/kft081 ![]() |
[54] |
Pompa PP, Vecchio G, Galeone A, et al. (2011) In Vivo toxicity assessment of gold nanoparticles in Drosophila melanogaster. Nano Res 4. https://doi.org/10.1007/s12274-011-0095-z ![]() |
[55] |
Castillo MH, Button TM, Doerr R, et al. (1988) Effects of radiotherapy on mandibular reconstruction plates. Am J Surg 156: 261-263. https://doi.org/10.1016/S0002-9610(88)80287-3 ![]() |
[56] |
Choi J, Kim G, Cho SB, et al. (2020) Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme. J Nanobiotechnol 18: 122. https://doi.org/10.1186/S12951-020-00684-5 ![]() |
[57] |
Cunningham C, de Kock M, Engelbrecht M, et al. (2021) Radiosensitization Effect of Gold Nanoparticles in Proton Therapy. Front Public Health 9. https://doi.org/10.3389/fpubh.2021.699822 ![]() |
[58] |
Chen Y, Yang J, Fu S, et al. (2020) Gold nanoparticles as radiosensitizers in cancer radiotherapy. Int J Nanomed 2020: 9407-9430. https://doi.org/10.2147/IJN.S272902 ![]() |
[59] |
Penninckx S, Heuskin AC, Michiels C, et al. (2020) Gold nanoparticles as a potent radiosensitizer: A transdisciplinary approach from physics to patient. Cancers 12: 2021. https://doi.org/10.3390/cancers12082021 ![]() |
[60] | Mousavie Anijdan SH, Mahdavi SR, Shirazi A, et al. (2013) Megavoltage X-ray Dose Enhancement with Gold Nanoparticles in Tumor Bearing Mice. Int J Mol Cell Med 2: 118-123. |
[61] | Choi BJ, Jung KO, Graves EE, et al. (2018) A gold nanoparticle system for the enhancement of radiotherapy and simultaneous monitoring of reactive-oxygen-species formation. Nanotechnology 29. https://doi.org/10.1088/1361-6528/aae272 |
[62] |
Ahmed AU, Tyler MA, Thaci B, et al. (2011) A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma. Mol Pharmaceut 8: 1559-1572. https://doi.org/10.1021/mp200161f ![]() |
[63] |
Schnarr K, Mooney R, Weng Y, et al. (2013) Gold Nanoparticle-Loaded Neural Stem Cells for Photothermal Ablation of Cancer. Adv Healthc Mater 2: 976-982. https://doi.org/10.1002/adhm.201300003 ![]() |
[64] |
Danyu M, Huile G, Wei G, et al. (2011) Anti glioma effect of doxorubicin loaded liposomes modified with Angiopep-2. Afr J Pharm Pharmaco 5: 409-414. https://doi.org/10.5897/AJPP11.068 ![]() |
[65] |
Zhang Y, Huang Y, Li S (2014) Polymeric micelles: Nanocarriers for cancer-targeted drug delivery. AAPS Pharm Sci Tech 15: 862-71. https://doi.org/10.1208/s12249-014-0113-z ![]() |
[66] |
Clavreul A, Pourbaghi-Masouleh M, Roger E, et al. (2017) Human mesenchymal stromal cells as cellular drug-delivery vectors for glioblastoma therapy: A good deal?. J Exp Clin Canc Res 36. https://doi.org/10.1186/s13046-017-0605-2 ![]() |
[67] | Upadhyay RK (2014) Drug delivery systems, CNS protection, and the blood brain barrier. BioMed Res Int 2014. https://doi.org/10.1155/2014/869269 |
[68] |
Kaneko N, Kako E, Sawamoto K (2011) Prospects and limitations of using endogenous neural stem cells for brain regeneration. Genes 2: 107-30. https://doi.org/10.3390/genes2010107 ![]() |
[69] |
Reynolds BA, Weiss S (1992) Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255: 1707-1710. https://doi.org/10.1126/SCIENCE.1553558 ![]() |
[70] |
Nagato M, Heike T, Kato T, et al. (2005) Prospective characterization of neural stem cells by flow cytometry analysis using a combination of surface markers. J Neurosci Res 80: 456-66. https://doi.org/10.1002/jnr.20442 ![]() |
[71] | Yuan SH, Martin J, Elia J, et al. (2011) Cell-surface marker signatures for the Isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS ONE 6. https://doi.org/10.1371/journal.pone.0017540 |
[72] |
Deshpande K, Saatian B, Martirosian V, et al. (2019) Isolation of Neural Stem Cells from Whole Brain Tissues of Adult Mice. Curr Protoc Stem Cell Biol 49. https://doi.org/10.1002/cpsc.80 ![]() |
[73] |
Casarosa S, Bozzi Y, Conti L (2014) Neural stem cells: ready for therapeutic applications?. Mol Cell Ther 2: 31. https://doi.org/10.1186/2052-8426-2-31 ![]() |
[74] |
Ottoboni L, von Wunster B, Martino G (2020) Therapeutic Plasticity of Neural Stem Cells. Front Neurol 11: 148. https://doi.org/10.3389/fneur.2020.00148 ![]() |
[75] |
Haus DL, López-Velázquez L, Gold EM, et al. (2016) Transplantation of human neural stem cells restores cognition in an immunodeficient rodent model of traumatic brain injury. Exp Neurol 281: 1-16. https://doi.org/10.1016/j.expneurol.2016.04.008 ![]() |
[76] |
Zhang S, Xie R, Zhao T, et al. (2014) Neural stem cells preferentially migrate to glioma stem cells and reduce their stemness phenotypes. Int J Oncol 45: 1989-96. https://doi.org/10.3892/ijo.2014.2629 ![]() |
[77] |
Jeong YJ, Jeung HA, Seung UK, et al. (2008) Migration of human neural stem cells toward an intracranial glioma. Exp Mol Med 40: 84-91. https://doi.org/10.3858/emm.2008.40.1.84 ![]() |
[78] |
Reagan MR, Kaplan DL (2011) Concise review: Mesenchymal stem cell tumor-homing: Detection methods in disease model systems. Stem Cells 29: 920-7. https://doi.org/10.1002/stem.645 ![]() |
[79] |
Aboody KS, Brown A, Rainov NG, et al. (2000) Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. P Natl Acad Sci USA 97: 12846-51. https://doi.org/10.1073/pnas.97.23.12846 ![]() |
[80] |
Mooney R, Roma L, Zhao D, et al. (2014) Neural stem cell-mediated intratumoral delivery of gold nanorods improves photothermal therapy. ACS Nano 8: 12450-60. https://doi.org/10.1021/nn505147w ![]() |
[81] |
Baghban R, Roshangar L, Jahanban-Esfahlan R, et al. (2020) Tumor microenvironment complexity and therapeutic implications at a glance. Cell Commun Signal 18. https://doi.org/10.1186/s12964-020-0530-4 ![]() |
[82] |
Albini A, Bruno A, Gallo C, et al. (2015) Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity. Connect Tissue Res 56. https://doi.org/10.3109/03008207.2015.1066780 ![]() |
[83] |
Hill BS, Pelagalli A, Passaro N, et al. (2017) Tumor-Educated mesenchymal stem cells promote Pro-Metastatic phenotype. Oncotarget 8: 73296-73311. https://doi.org/10.18632/oncotarget.20265 ![]() |
[84] |
Carey-Ewend AG, Hagler SB, Bomba HN, et al. (2021) Developing Bioinspired Three-Dimensional Models of Brain Cancer to Evaluate Tumor-Homing Neural Stem Cell Therapy. Tissue Eng Pt A 27: 857-866. https://doi.org/10.1089/ten.tea.2020.0113 ![]() |
[85] |
Xu JT, Qian Y, Wang W, et al. (2020) Effect of stromal cell-derived factor-1/CXCR4 axis in neural stem cell transplantation for Parkinson's disease. Neural Regen Res 15: 112-9. https://doi.org/10.4103/1673-5374.264470 ![]() |
[86] |
Heese O, Disko A, Zirkel D, et al. (2005) Neural stem cell migration toward gliomas in vitro. Neuro-Oncology 7: 476-84. https://doi.org/10.1215/S1152851704000754 ![]() |
[87] |
Schmidt NO, Przylecki W, Yang W, et al. (2005) Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7: 623-30. https://doi.org/10.1593/neo.04781 ![]() |
[88] |
Miska J, Lesniak MS (2015) Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme. EBioMedicine 2: 774-5. https://doi.org/10.1016/j.ebiom.2015.08.022 ![]() |